IL-4 Protein, Human

63 Cited Publications
Customer Review

Based on 63 publication(s) in Google Scholar

IL-4 Protein is an endogenous agonist of IL-4 receptor (IL-4R), which works through the JAK1/JAK3-STAT6 signaling pathway. It can cooperate with SCF to promote the proliferation of human intestinal mast cells (ED50=100 pg/mL) and enhance the release of mediators such as histamine mediated by IgE receptor. IL-4 Protein can inhibit the production of IL-8 by human monocytes and regulate the secretion of endothelial cell factors. It is mainly used for IL-4R targeted therapy research of tumors (such as malignant pleural mesothelioma) and allergic diseases. IL-4 Protein, Human is a recombinant protein of human IL-4, expressed by E. coli, with tag free.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: E. coli
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • References
  • Help & FAQs

Biological Activity

Description

IL-4 Protein is an endogenous agonist of IL-4 receptor (IL-4R), which works through the JAK1/JAK3-STAT6 signaling pathway. It can cooperate with SCF to promote the proliferation of human intestinal mast cells (ED50=100 pg/mL) and enhance the release of mediators such as histamine mediated by IgE receptor. IL-4 Protein can inhibit the production of IL-8 by human monocytes and regulate the secretion of endothelial cell factors. It is mainly used for IL-4R targeted therapy research of tumors (such as malignant pleural mesothelioma) and allergic diseases. IL-4 Protein, Human is a recombinant protein of human IL-4, expressed by E. coli, with tag free.

Background

IL-4 Protein is a cytokine of the interleukin-4 family, a glycoprotein with an α-helical structure, and an endogenous agonist of the IL-4 receptor (IL-4R), binding to the IL-4Rα and γc chains. IL-4 Protein was originally called B cell growth factor BSF1 and was described in the supernatant of activated EL-4 thymoma cells to costimulate with subservient concentrations of anti-IgM. IL-4 Protein exerts biological activity through the JAK1/JAK3-STAT6 signaling pathway, and can promote the proliferation of human intestinal mast cells (ED50=100 pg/mL) in coordination with stem cell factor (SCF), enhance the release of histamine, leukotriene C4, and IL-5 mediated by IgE receptors, inhibit the secretion of IL-8 mRNA and protein by human monocytes stimulated by LPS/TNF-α/IL-1β, and selectively enhance the secretion of IL-6 and inhibit IL-8 by human umbilical vein endothelial cells. Its mechanism of action involves regulating the expression of cell membrane receptors and the activation of downstream transcription factors. It is mainly used in the study of immune regulation mechanisms and targeted therapy of allergic diseases (such as asthma) and tumors (such as malignant pleural mesothelioma), especially the application of IL-4R-targeted cytotoxin fusion proteins (such as IL-4-PE, cpIL-4-PE) in tumor ablation. IL-4 Protein plays an important role in regulating inflammation and immune response. IL-4 Protein induces naive helper T cells to differentiate into Th2 cells. While IL-4 Protein binds to the IL-4 receptor, the IL-4 receptor also binds to another cytokine, IL-13, which may explain the overlapping functions of IL-4 and IL-13[1][2][3][4][5].

Verified Bioactivity

The cell proliferation assay using TF-1 human erythroleukemic cells has an ED50 value of ≤450 pg/mL.

Results
  • Experimental Validation Results for IL-4 Protein, Human
    Measured in a cell proliferation assay using TF-1 human erythroleukemic cells.The ED50 for this effect is 0.2989 ng/mL., corresponding to a specific activity is 3.35×106 U/mg

Technical Parameters

  • Species Human
  • Source E. coli
  • Tag Tag Free
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • IL-4 (H25-S153)
      Accession # P05112-1
    • C-term
  • Protein Length

    Full Length of Isoform-1 Mature Protein

  • Synonyms

    Interleukin-4; IL-4; B-Cell Stimulatory Factor 1; BSF-1; Binetrakin; Lymphocyte Stimulatory Factor 1; Pitrakinra; IL4

  • AA Sequence

    HKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS

  • Predicted Molecular Mass

    15.1 kDa

  • Molecular Weight

    Approximately 13-14 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

    • Experimental Validation Results for IL-4 Protein, Human
      ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder

Formulation

1.Lyophilized from a 0.22 μm filtered solution of 20 mM Tris-HCl, 150 mM NaCl, pH 7.2.
2.Lyophilized from a 0.22 μm filtered solution of 50 mM Tris-HCl, 300 mM NaCl, pH 8.0.
3.Lyophilized from a 0.22 μm filtered solution of 50 mM Tris-HCl, 300 mM NaCl, pH 8.0, 5% trehalose.
4.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 8% trehalose.
Please refer to the lot-specific COA for specific buffer information.
Note: For SPR assay, please replace the buffer. Primary amine components (e.g., Tris, imidazole) can affect protein-coupled chips.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

References

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00